REPL Replimune Group, Inc.

1d ago, source: Seeking Alpha

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company’s proprietary tumor-directed oncolytic ...

Replimune Group (NASDAQ: REPL)

7d ago, source: The Motley Fool

Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Its product candidates ...

Replimune Promotes Sushil Patel To Succeed Philip Astley-Sparke As CEO

1mon ago, source: Business Insider

(RTTNews) - Biotechnology company Replimune Group, Inc. (REPL) announced Tuesday changes to its executive leadership team designed to support the Company's preparations for the commercial launch ...

Replimune Group Inc (REPL) Shares Rise Despite Market Challenges

12d ago, source: newsheater

In conclusion, Replimune Group Inc (REPL) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s ...

Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions

1mon ago, source: Business Insider

March 26, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies ...

Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions

1mon ago, source: Stockhouse

WOBURN, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, ...

Replimune Group, Inc. (REPL)

6d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Replimune Group Inc REPL

17d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Replimune Group Inc REPL

8d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Replimune Group Inc.

16d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...